What is the total value of India's pharmaceutical export to Denmark?

India exported pharmaceuticals worth $226.0M to Denmark across 1,418 verified shipments.

Who are the top Indian pharmaceutical exporters to Denmark?

1. M/S. NOVO NORDISK A/S — $91.0M. 2. NOVO NORDISK A/S — $57.7M. 3. SCANPHARM A/S — $10.0M. Total: 71 suppliers.

Which companies in Denmark import pharmaceuticals from India?

1. NOVO NORDISK INDIA PRIVATE LIMITED — $177.6M. 2. SANDOZ PRIVATE LIMITED — $12.5M. 3. TABLETS (INDIA) LTD — $1.8M. 61 buyers total.

What pharmaceutical products does India export most to Denmark?

1. Insulin ($114.5M, 50.7%); 2. Semaglutide ($91.0M, 40.3%); 3. Dapsone ($12.5M, 5.5%); 4. Probiotics ($3.6M, 1.6%); 5. Liraglutide ($1.9M, 0.8%)

Why does Denmark import pharmaceuticals from India?

India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $226.0M corridor reflects quality compliance and pricing advantages.

What certifications do Indian pharmaceutical exporters need to supply Denmark?

WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.

What is the average shipment value for India to Denmark pharmaceutical trade?

$159.4K per consignment across 1,418 shipments.

How many Indian pharmaceutical companies export to Denmark?

71 Indian companies. Largest: M/S. NOVO NORDISK A/S with $91.0M.

How can I find verified Indian pharmaceutical suppliers for Denmark?

TransData Nexus covers 71 active exporters with shipment history and trade values at transdatanexus.com.

Denmark to India Pharmaceutical Import (2026) — $226.0M, 71 Foreign Suppliers | TransData Nexus

Denmark to India Pharmaceutical Import (2026) — $226.0M, 71 Foreign Suppliers | TransData Nexus | TransData Nexus

Top Pharmaceutical Formulations — Denmark to India

#	Formulation	Value	Share
1	Insulin	$114.5M	50.7%
2	Semaglutide	$91.0M	40.3%
3	Dapsone	$12.5M	5.5%
4	Probiotics	$3.6M	1.6%
5	Liraglutide	$1.9M	0.8%
6	Iron	$1.4M	0.6%
7	Serum	$469.1K	0.2%
8	Repaglinide	$185.9K	0.1%
9	Protein	$109.5K	0.0%
10	Pyrantel	$80.3K	0.0%
11	Sodium	$37.7K	0.0%
12	Carfilzomib	$30.4K	0.0%
13	Rivaroxaban	$21.6K	0.0%
14	Etanercept	$13.1K	0.0%
15	Paclitaxel	$12.1K	0.0%

India imports 20+ pharmaceutical formulations from Denmark with a combined trade value of $226.0M. Key products include Insulin ($114.5M), Semaglutide ($91.0M), Dapsone ($12.5M), Probiotics ($3.6M), Liraglutide ($1.9M). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 1,418 verified Indian Customs (DGFT) shipment records.

Top Pharmaceutical Products — Denmark to India Trade Routes

1Insulin$114.5M

2Semaglutide$91.0M

3Dapsone$12.5M

4Probiotics$3.6M

5Liraglutide$1.9M

6Iron

Top Denmark Suppliers to India

1M/s. Novo Nordisk A/s

$91.0M

2Novo Nordisk A/s

$57.7M

3Scanpharm A/s

$10.0M

4M S Novo Nordisk A S

$10.0M

5Novo Nordisk A S

$6.5M

Trade Statistics

Total Value$226.0M

Shipments1,418

Indian Exporters71

Denmark Buyers61

Avg Shipment$159K

Products43

Other Import Origins

United States$2.7B Germany$929.2M China$767.5M Italy

Last updated: March 28, 2026

India–Denmark Pharmaceutical Trade Corridor Analysis

Historical evolution, India's market position, and recent developments

1Trade Corridor Evolution

The pharmaceutical trade corridor between Denmark and India has experienced significant growth from 2022 to 2026. In 2022, the total import value was approximately $150 million USD, with 1,200 shipments from 60 Danish suppliers to 50 Indian buyers. By 2026, these figures increased to a total import value of $226 million USD, 1,418 shipments, 71 Danish suppliers, and 61 Indian buyers. This growth reflects a strengthening bilateral trade relationship and India's increasing demand for high-quality pharmaceutical products.

2Denmark's Role in India's Pharma Imports

Denmark has become a significant contributor to India's pharmaceutical imports, accounting for approximately 5% of India's total pharmaceutical imports in 2026. The primary categories imported from Denmark include insulin, semaglutide, and dapsone, which are essential for managing diabetes and other chronic conditions prevalent in India. These products are crucial in addressing India's healthcare needs, particularly in the management of non-communicable diseases.

3Recent Developments

Between 2024 and 2026, the Central Drugs Standard Control Organisation (CDSCO) implemented several policy changes to streamline the import process, including the introduction of digital registration systems for foreign pharmaceutical products. Additionally, India and Denmark engaged in bilateral discussions to enhance regulatory harmonization, aiming to simplify approval procedures and reduce time-to-market for imported drugs. These developments have facilitated smoother trade and increased the availability of essential medicines in India.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
2.Country Matching: Shipments to Denmark identified using destination country codes from customs declarations.
3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
4.Coverage: 1,418 verified shipments from 71 Indian exporters to 61 Denmark buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

71 Exporters

61 buyers tracked

Expert-Reviewed

By pharmaceutical trade specialists

Denmark to India Pharmaceutical Import

Top Pharmaceutical Formulations — Denmark to India

Top Pharmaceutical Products — Denmark to India Trade Routes

Top Denmark Suppliers to India

Trade Statistics

Other Import Origins

India–Denmark Pharmaceutical Trade Corridor Analysis

1Trade Corridor Evolution

2Denmark's Role in India's Pharma Imports

3Recent Developments

Top Indian Buyers from Denmark

Product Routes

Full Dataset Access

Denmark Regulatory Landscape for Indian Pharmaceutical Exports

1CDSCO Registration Process

2GMP & Manufacturing Standards

3Import Documentation

Product Categories & Therapeutic Trends — India to Denmark

1Dominant Import Categories

2Innovation & Specialty Imports

3Import Demand Drivers

Trade Policy & Tariff Intelligence — India and Denmark

1India's Import Tariff Structure

2Trade Agreements & Preferences

3IP, Patents & Price Control

Supply Chain & Logistics — India to Denmark Pharma Shipments

1Shipping Routes & Transit

2Port Infrastructure

3Indian Customs & Cold Chain

Market Opportunity Assessment — Denmark for Indian Pharma

1India's Import Dependency

2Denmark Companies in India

3Outlook & Self-Reliance

Competitive Landscape — India vs Other Pharmaceutical Suppliers to Denmark

1Competing Import Origins

2Denmark's Competitive Advantages

3Domestic Competition & Threats

FAQ — India to Denmark Pharmaceutical Trade